|
WO2013040238A2
|
|
Sustained release ocular drug delivery devices and methods of manufacture
|
|
EP2632532A2
|
|
Devices for delivering at least one active agent to tissue
|
|
US2010233241A1
|
|
Ophthalmic drug delivery system and applications
|
|
EP1658109A2
|
|
Ocular drug delivery device
|
|
CA2536061A1
|
|
Polymeric systems for controlled drug therapy
|
|
WO03028751A1
|
|
Glycoprotein and/or glycomacropeptide containing ophthalmic preparation
|
|
WO03013477A1
|
|
Drug release system for controlled therapy
|
|
US6429194B1
|
|
Mucin containing ophthalmic preparation
|
|
WO0124837A1
|
|
Preservative system for ophthalmic solutions
|
|
WO0123509A1
|
|
Composition and method for treating contact lenses
|
|
WO0070003A1
|
|
Contact lens cleaning solution
|
|
US6281192B1
|
|
Mucin containing ophthalmic preparations
|
